Hjem › Kronisk nyresygdom › Washington › Seattle
Kronisk nyresygdom kliniske forsøg i Seattle, WA
5 studier for Kronisk nyresygdom søger deltagere på steder i og omkring Seattle (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RekruttererFase 3
- Research Site, Seattle
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
RekruttererFase 3
- Seattle Children's Hospital, Seattle
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
RekruttererFase 3
- Research Site, Seattle
Kidney Precision Medicine Project
RekruttererObservationsstudie
- University of Washington, Seattle
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
Rekrutterer
- University of Washington, Seattle
Kronisk nyresygdom forsøg i andre byer
- New York City, NY16 studier
- Houston, TX15 studier
- Boston, MA15 studier
- Dallas, TX15 studier
- Philadelphia, PA15 studier
- Chicago, IL12 studier
- Orlando, FL11 studier
- Atlanta, GA10 studier
- Kansas City, MO9 studier
- Durham, NC9 studier
- Washington, DC8 studier
- Albuquerque, NM8 studier
Andre studier i Seattle
- Ikke-småcellet lungecancer53 studier
- Kræft (alle typer)49 studier
- Prostatakræft42 studier
- Akut myeloid leukæmi40 studier
- Brystkræft39 studier
- Metastatisk cancer39 studier
- Colorektal kræft34 studier
- Lungecancer33 studier
- Ægstockræft30 studier
- Multipelt myelom22 studier
- Myelodysplastiske syndromer21 studier
- Akut lymfoblastisk leukæmi21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.